Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: Role in redox signaling and vascular hypertrophy

Lian Zuo, Masuko Ushio-Fukai, Satoshi Ikeda, Lula Hilenski, Nikolay Patrushev, R. Wayne Alexander

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Objective - Angiotensin II (Ang II) is a potent mediator of vascular hypertrophy in vascular smooth muscle cells (VSMCs). These effects are mediated through the Ang II type 1 receptor (AT1R) and require its trafficking through caveolin-1 (Cav1)-enriched lipid rafts and reactive oxygen species (ROS) derived from Rac1-dependent NAD(P)H oxidase. The specific role(s) of Cav1 in AT1R signaling is incompletely understood. Methods and Results - Knockdown of Cav1 protein by small interfering RNA (siRNA) inhibits Ang II-stimulated Rac1 activation and membrane translocation, H2O 2 production, ROS-dependent epidermal growth factor receptor (EGF-R) transactivation, and subsequent phosphorylation of Akt without affecting ROS-independent extracellular signal-regulated kinase 1/2 phosphorylation. Ang II stimulates tyrosine phosphorylation of Sos-1, a Rac-guanine nucleotide exchange factor, which is inhibited by Cav1 siRNA, demonstrating involvement of Cav1 in Rac1 activation. Detergent-free fractionation showed that EGF-Rs are found basally in Cav1-enriched lipid raft membranes and associate with Cav1. Ang II stimulates AT1R movement into these microdomains contemporaneously with the egress of EGF-R. Both aspects of this bidirectional receptor trafficking are inhibited by Cav1 siRNA. Moreover, Cav1 siRNA inhibits Ang II-induced vascular hypertrophy. Conclusions - Cav1 plays an essential role in AT1R targeting into Cav1-enriched lipid rafts and Rac1 activation, which are required for proper organization of ROS-dependent Ang II signaling linked to VSMC hypertrophy.

Original languageEnglish (US)
Pages (from-to)1824-1830
Number of pages7
JournalArteriosclerosis, thrombosis, and vascular biology
Volume25
Issue number9
DOIs
StatePublished - Sep 1 2005

Fingerprint

Caveolin 1
Angiotensin Type 1 Receptor
NADPH Oxidase
Vascular Smooth Muscle
Hypertrophy
Oxidation-Reduction
Smooth Muscle Myocytes
Blood Vessels
Angiotensin II
Small Interfering RNA
Reactive Oxygen Species
Phosphorylation
Epidermal Growth Factor
Caveolins
Lipids
Guanine Nucleotide Exchange Factors
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Membrane Lipids
Epidermal Growth Factor Receptor

Keywords

  • Angiotensin II
  • Caveolae
  • Caveolin
  • Reactive oxygen species
  • Vascular hypertrophy
  • Vascular smooth muscle

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells : Role in redox signaling and vascular hypertrophy. / Zuo, Lian; Ushio-Fukai, Masuko; Ikeda, Satoshi; Hilenski, Lula; Patrushev, Nikolay; Alexander, R. Wayne.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 25, No. 9, 01.09.2005, p. 1824-1830.

Research output: Contribution to journalArticle

@article{9b0c0a4258c648dbbba330add21ef7e3,
title = "Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: Role in redox signaling and vascular hypertrophy",
abstract = "Objective - Angiotensin II (Ang II) is a potent mediator of vascular hypertrophy in vascular smooth muscle cells (VSMCs). These effects are mediated through the Ang II type 1 receptor (AT1R) and require its trafficking through caveolin-1 (Cav1)-enriched lipid rafts and reactive oxygen species (ROS) derived from Rac1-dependent NAD(P)H oxidase. The specific role(s) of Cav1 in AT1R signaling is incompletely understood. Methods and Results - Knockdown of Cav1 protein by small interfering RNA (siRNA) inhibits Ang II-stimulated Rac1 activation and membrane translocation, H2O 2 production, ROS-dependent epidermal growth factor receptor (EGF-R) transactivation, and subsequent phosphorylation of Akt without affecting ROS-independent extracellular signal-regulated kinase 1/2 phosphorylation. Ang II stimulates tyrosine phosphorylation of Sos-1, a Rac-guanine nucleotide exchange factor, which is inhibited by Cav1 siRNA, demonstrating involvement of Cav1 in Rac1 activation. Detergent-free fractionation showed that EGF-Rs are found basally in Cav1-enriched lipid raft membranes and associate with Cav1. Ang II stimulates AT1R movement into these microdomains contemporaneously with the egress of EGF-R. Both aspects of this bidirectional receptor trafficking are inhibited by Cav1 siRNA. Moreover, Cav1 siRNA inhibits Ang II-induced vascular hypertrophy. Conclusions - Cav1 plays an essential role in AT1R targeting into Cav1-enriched lipid rafts and Rac1 activation, which are required for proper organization of ROS-dependent Ang II signaling linked to VSMC hypertrophy.",
keywords = "Angiotensin II, Caveolae, Caveolin, Reactive oxygen species, Vascular hypertrophy, Vascular smooth muscle",
author = "Lian Zuo and Masuko Ushio-Fukai and Satoshi Ikeda and Lula Hilenski and Nikolay Patrushev and Alexander, {R. Wayne}",
year = "2005",
month = "9",
day = "1",
doi = "10.1161/01.ATV.0000175295.09607.18",
language = "English (US)",
volume = "25",
pages = "1824--1830",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells

T2 - Role in redox signaling and vascular hypertrophy

AU - Zuo, Lian

AU - Ushio-Fukai, Masuko

AU - Ikeda, Satoshi

AU - Hilenski, Lula

AU - Patrushev, Nikolay

AU - Alexander, R. Wayne

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Objective - Angiotensin II (Ang II) is a potent mediator of vascular hypertrophy in vascular smooth muscle cells (VSMCs). These effects are mediated through the Ang II type 1 receptor (AT1R) and require its trafficking through caveolin-1 (Cav1)-enriched lipid rafts and reactive oxygen species (ROS) derived from Rac1-dependent NAD(P)H oxidase. The specific role(s) of Cav1 in AT1R signaling is incompletely understood. Methods and Results - Knockdown of Cav1 protein by small interfering RNA (siRNA) inhibits Ang II-stimulated Rac1 activation and membrane translocation, H2O 2 production, ROS-dependent epidermal growth factor receptor (EGF-R) transactivation, and subsequent phosphorylation of Akt without affecting ROS-independent extracellular signal-regulated kinase 1/2 phosphorylation. Ang II stimulates tyrosine phosphorylation of Sos-1, a Rac-guanine nucleotide exchange factor, which is inhibited by Cav1 siRNA, demonstrating involvement of Cav1 in Rac1 activation. Detergent-free fractionation showed that EGF-Rs are found basally in Cav1-enriched lipid raft membranes and associate with Cav1. Ang II stimulates AT1R movement into these microdomains contemporaneously with the egress of EGF-R. Both aspects of this bidirectional receptor trafficking are inhibited by Cav1 siRNA. Moreover, Cav1 siRNA inhibits Ang II-induced vascular hypertrophy. Conclusions - Cav1 plays an essential role in AT1R targeting into Cav1-enriched lipid rafts and Rac1 activation, which are required for proper organization of ROS-dependent Ang II signaling linked to VSMC hypertrophy.

AB - Objective - Angiotensin II (Ang II) is a potent mediator of vascular hypertrophy in vascular smooth muscle cells (VSMCs). These effects are mediated through the Ang II type 1 receptor (AT1R) and require its trafficking through caveolin-1 (Cav1)-enriched lipid rafts and reactive oxygen species (ROS) derived from Rac1-dependent NAD(P)H oxidase. The specific role(s) of Cav1 in AT1R signaling is incompletely understood. Methods and Results - Knockdown of Cav1 protein by small interfering RNA (siRNA) inhibits Ang II-stimulated Rac1 activation and membrane translocation, H2O 2 production, ROS-dependent epidermal growth factor receptor (EGF-R) transactivation, and subsequent phosphorylation of Akt without affecting ROS-independent extracellular signal-regulated kinase 1/2 phosphorylation. Ang II stimulates tyrosine phosphorylation of Sos-1, a Rac-guanine nucleotide exchange factor, which is inhibited by Cav1 siRNA, demonstrating involvement of Cav1 in Rac1 activation. Detergent-free fractionation showed that EGF-Rs are found basally in Cav1-enriched lipid raft membranes and associate with Cav1. Ang II stimulates AT1R movement into these microdomains contemporaneously with the egress of EGF-R. Both aspects of this bidirectional receptor trafficking are inhibited by Cav1 siRNA. Moreover, Cav1 siRNA inhibits Ang II-induced vascular hypertrophy. Conclusions - Cav1 plays an essential role in AT1R targeting into Cav1-enriched lipid rafts and Rac1 activation, which are required for proper organization of ROS-dependent Ang II signaling linked to VSMC hypertrophy.

KW - Angiotensin II

KW - Caveolae

KW - Caveolin

KW - Reactive oxygen species

KW - Vascular hypertrophy

KW - Vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=24144471786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144471786&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000175295.09607.18

DO - 10.1161/01.ATV.0000175295.09607.18

M3 - Article

C2 - 15976327

AN - SCOPUS:24144471786

VL - 25

SP - 1824

EP - 1830

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 9

ER -